Cost-effectiveness Clinical Trials

8 recruitingLast updated: May 21, 2026

There are 8 actively recruiting cost-effectiveness clinical trials across 6 countries. Studies span Not Applicable. Top locations include Taipei, Taiwan, Ghent, Belgium, Kaohsiung City, Taiwan, Taiwan. Updated daily from ClinicalTrials.gov.


Cost-effectiveness Trials at a Glance

8 actively recruiting trials for cost-effectiveness are listed on ClinicalTrialsFinder across 6 cities in 6 countries. The largest study group is Not Applicable with 5 trials, with the heaviest enrollment activity in Taipei, Ghent, and Kaohsiung City. Lead sponsors running cost-effectiveness studies include China Medical University Hospital, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, and Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh.

Browse cost-effectiveness trials by phase

About Cost-effectiveness Clinical Trials

Looking for clinical trials for Cost-effectiveness? There are currently 4 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Cost-effectiveness trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Cost-effectiveness clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting
Not Applicable

Develop and Evaluate An Artificial Intelligence Assisted Prehabilitation Program for Returning to Work and Cost-effectiveness Analysis in Patients With Oral Cancer

PhysiotherapyQuality of LifePrehabilitation+11 more
Taipei Veterans General Hospital, Taiwan650 enrolled5 locationsNCT07562100
Recruiting
Not Applicable

The Impact of Artificial Intelligence Electrocardiography on Occlusion Myocardial Infarction Management Under the Value-Based Payment System

Artificial Intelligence (AI)ElectrocardiogramCost-effectiveness Analysis+1 more
National Defense Medical Center, Taiwan212,000 enrolled3 locationsNCT06887699
Recruiting

Comparing Myopia Treatments in Youth: Defocus Spectacles, Glasses, and Ortho-K

Quality of LifeMyopiaCost-effectiveness Analysis
He Eye Hospital90 enrolled1 locationNCT06278974
Recruiting
Not Applicable

Pediatric Airway: Noninferiority Trial of Devices for Intubation Assessment

Airway ManagementVideo LaryngoscopeIntubation Intratracheal+1 more
University of Sao Paulo General Hospital226 enrolled1 locationNCT07351227
Recruiting
Not Applicable

Effectiveness of the AI-Supporter in Reducing Urinary Tract Infections

IncontinenceUrinary Tract InfectionIncontinence-associated Dermatitis+1 more
China Medical University Hospital60 enrolled1 locationNCT06613503
Recruiting

Comparative Analysis of Cost-effectiveness Between Sulfonylureas and DPP4 Inhibitors in Combination With Metformin in Treatment of Type 2 Diabetic Patients : A Retrospective, Observational Study.

Type 2 Diabetes Mellitus (T2DM), Cost-effectiveness, Sulfonylureas, DPP4 Inhibitors, Metformin
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh200 enrolled1 locationNCT06570980
Recruiting

Cost-effectiveness Analysis of an Antimicrobial Stewardship Program in Regione Lombardia (RF-net2018)

Antimicrobial StewardshipCost-effectiveness Analysis
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico50,000 enrolled1 locationNCT06388278
Recruiting
Not Applicable

Home-based Exercise and Physical Activity Intervention After Kidney Transplantation: Impact of Exercise Intensity

Exercise TrainingPhysical ActivityImplementation+6 more
KU Leuven147 enrolled2 locationsNCT06260579